Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Related news about the opioid crisis and improving patient outcomes
Luis Garcia is giving away free doses of the lifesaving drug to local businesses that could potentially encounter an overdose
Alton Banks apparently encountered the drug during a one-hour period after he left a pool and got home
Test your knowledge of fentanyl exposure, protection and treatment
The drug will be available without a prescription in 45 states, and Walgreens said they are “eager and willing” to increase that number
The University of Minnesota is researching how they can equip ambulances with the latest imaging and heart-lung bypass technology
From fentanyl, to heroin, to ketamine, to carfentanil: the drug epidemic didn’t start in the back of an ambulance
There is concern the White House actions will be empty talk without a long-term commitment to paying for more addiction treatment
A study of four states estimated that 13 percent to 35 percent of the Medicaid expansion population abused or were dependent on opioids
Officials said a third student became ill at the high school from taking an unknown drug
Researchers found that cardiac arrest survival rates remain low in the U.K. due to the lack of knowledge and skills to perform CPR
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.